These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 33356420

  • 21. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
    Tandstad T, Solberg A, Håkansson U, Stahl O, Haugnes HS, Oldenburg J, Dahl O, Kjellman A, Angelsen A, Cohn-Cedermark G, SWENOTECA.
    Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
    [Abstract] [Full Text] [Related]

  • 22. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
    Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1056-66. PubMed ID: 16030303
    [Abstract] [Full Text] [Related]

  • 23. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
    Souchon R, Gertenbach U, Dieckmann KP, Hahn E, Ruwe M, Stambolis C, Loy V, Classen J.
    Strahlenther Onkol; 2006 May 20; 182(5):289-92. PubMed ID: 16673063
    [Abstract] [Full Text] [Related]

  • 24. Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature.
    Thorsen L, Haugnes HS, Fosså SD, Brydøy M, Tandstad T, Wisløff T, Gjerset GM, Edvardsen E, Larsen KO, Sandset PM, Henriksson CE, Raastad T, Negaard HFS.
    Int J Cancer; 2020 Dec 01; 147(11):3189-3198. PubMed ID: 32525564
    [Abstract] [Full Text] [Related]

  • 25. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
    Kier MGG, Lauritsen J, Almstrup K, Mortensen MS, Toft BG, Rajpert-De Meyts E, Skakkebaek NE, Rørth M, von der Maase H, Agerbaek M, Holm NV, Andersen KK, Dalton SO, Johansen C, Daugaard G.
    Ann Oncol; 2015 Apr 01; 26(4):737-742. PubMed ID: 25542924
    [Abstract] [Full Text] [Related]

  • 26. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S.
    Lancet Oncol; 2014 Dec 01; 15(13):1442-1450. PubMed ID: 25456363
    [Abstract] [Full Text] [Related]

  • 27. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
    de Haas EC, Zwart N, Meijer C, Nuver J, Boezen HM, Suurmeijer AJ, Hoekstra HJ, van der Steege G, Sleijfer DT, Gietema JA.
    J Clin Oncol; 2008 Apr 10; 26(11):1817-23. PubMed ID: 18398146
    [Abstract] [Full Text] [Related]

  • 28. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC, Pedrosa JA, Kaimakliotis HZ, Masterson TA, Einhorn LH, Foster RS.
    J Urol; 2015 Feb 10; 193(2):507-12. PubMed ID: 25254937
    [Abstract] [Full Text] [Related]

  • 29. Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic era.
    Park DS, Prow DM, Amato RJ, Ro JY, Logothetis CJ.
    Yonsei Med J; 1999 Apr 10; 40(2):137-43. PubMed ID: 10333717
    [Abstract] [Full Text] [Related]

  • 30. Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer.
    Heidegger I, Porres D, Veek N, Heidenreich A, Pfister D.
    Urol Int; 2017 Apr 10; 99(1):104-109. PubMed ID: 28514776
    [Abstract] [Full Text] [Related]

  • 31. Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer.
    van Basten JP, Hoekstra HJ, van Driel MF, Sleijfer DT, Droste JH, Schraffordt Koops H.
    Ann Surg Oncol; 1997 Jun 10; 4(4):342-8. PubMed ID: 9181235
    [Abstract] [Full Text] [Related]

  • 32. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group.
    J Clin Oncol; 2008 Jun 20; 26(18):2966-72. PubMed ID: 18458040
    [Abstract] [Full Text] [Related]

  • 33. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
    Suer E, Mermerkaya M, Gülpınar Ö, Afandiyev F, Baltacı S, Türkölmez K, Bedük Y.
    J Urol; 2013 Dec 20; 190(6):2081-5. PubMed ID: 23764076
    [Abstract] [Full Text] [Related]

  • 34. Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer.
    Mezvrishvili Z, Managadze L.
    Int Urol Nephrol; 2006 Dec 20; 38(3-4):621-4. PubMed ID: 17111082
    [Abstract] [Full Text] [Related]

  • 35. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
    Ishioka J, Fujii Y, Kageyama Y, Fukuda H, Higashi Y, Kihara K.
    Int J Urol; 2008 Jul 20; 15(7):642-5. PubMed ID: 18643784
    [Abstract] [Full Text] [Related]

  • 36. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 37. [Late toxicity after chemotherapy of malignant testicular tumors].
    Jakob A, Kollmannsberger C, Kanz L, Bokemeyer C.
    Urologe A; 1998 Nov 01; 37(6):635-47. PubMed ID: 9887493
    [Abstract] [Full Text] [Related]

  • 38. Metachronous bilateral testicular germ cell tumors: report of two cases.
    James FV, Kumar A, Jayaprakash PG, Mathews A.
    J Cancer Res Ther; 2009 Nov 01; 5(3):206-7. PubMed ID: 19841564
    [Abstract] [Full Text] [Related]

  • 39. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
    Haugnes HS, Stenklev NC, Brydøy M, Dahl O, Wilsgaard T, Laukli E, Fosså SD.
    Acta Oncol; 2018 Aug 01; 57(8):1075-1083. PubMed ID: 29384420
    [Abstract] [Full Text] [Related]

  • 40. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
    Nichols CR, Breeden ES, Loehrer PJ, Williams SD, Einhorn LH.
    J Natl Cancer Inst; 1993 Jan 06; 85(1):36-40. PubMed ID: 7677934
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.